The US Food and Drug Administration (FDA) has stood by an earlier decision confirming that the tirzepatide shortage is over.

Their symptom improvement was likely thanks to their weight loss, the FDA said. Zepbound is a glucagon-like peptide 1 drug ...

Undiagnosed or untreated EPI could result in muscle loss since the patient isn’t absorbing the necessary nutrients.

Consumers who take copies of the weight loss drug Zepbound and diabetes drug Mounjaro will need to find a new source for ...

"An MDL that encompassed any potential injury relating to use of these exceedingly popular weight loss drugs might quickly ...

All products are independently selected by our editors. If you buy something, we may earn an affiliate commission.

Since pharmaceutical giant Eli Lilly (NYSE: LLY) reported earnings for the third quarter on Oct. 30, shares have been ...

Some people are not taking weight-loss medications responsibly, the physician says, and don't realize their full implications ...

Eli Lilly just gave investors several reasons to cheer.

“Today’s approval marks the first drug treatment option for certain patients with obstructive sleep apnea,” said Sally ...

The following is a summary of “Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity,” published in the ...

Obesity and family practice experts share when it’s safe to prescribe GLP-1 receptor agonists to patients with thyroid ...